Share

October 2013; 3 (5) Clinical and Ethical Challenges

Hydration status substantially affects chronic cerebrospinal venous insufficiency assessments

Claudiu I. Diaconu, Robert J. Fox, Alia Grattan, Alexander Rae-Grant, Mei Lu, Heather L. Gornik, Esther Soo H. Kim
First published October 3, 2013, DOI: https://doi.org/10.1212/CPJ.0b013e3182a78f15
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
697

Share

Article Information

vol. 3 no. 5 386-391
DOI: 
https://doi.org/10.1212/CPJ.0b013e3182a78f15
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published October 3, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Claudiu I. Diaconu, BS,
    2. Robert J. Fox, MD,
    3. Alia Grattan, RVT,
    4. Alexander Rae-Grant, MD,
    5. Mei Lu, MD, PhD,
    6. Heather L. Gornik, MD, MPH, RPVI and
    7. Esther Soo H. Kim, MD, MPH, RPVI
  1. Claudiu I. Diaconu, BS,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Robert J. Fox, MD,
    3. Scientific Advisory Boards:

    1. Biogen Idec, Novartis

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial Board, Neurology Editorial Board, Multiple Sclerosis Journal

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Allozyne, Avanir, Biogen Idec, Novartis, Questcor, EMD Serono, and Teva Neurosciences.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Research grant from Novartis.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National MS Society, RG 3548A2, 2004-2009; RG 4091A3/1 2009-2012; RG 4103A4/2, 2009-2011; RC 1004-A-5, 2010- 2012.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Alia Grattan, RVT,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Alexander Rae-Grant, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Biogen Idec, speaker honorarium. Teva Neurosciences, speaker honorarium, Avanir, Speaker honorarium, Novartis, Speaker honorarium

    Editorial Boards:

    1. Neurology, Evidence Review Team, 2011-2013

    Patents:

    1. NONE

    Publishing Royalties:

    1. Handbook of Multiple Sclerosis, Springer Healthcare, 2010, Comprehensive review of clinical neurology, Wolters Kluwer, 2012, 5 minute consult in neurology, Wolters Klower, 2012

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. Biogen IDEC

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. CO-PI 4% effort FMRI as an imaging biomarker for preclinical Alzheimer's disease NIH grant #A6022304, 5/15/10-4/30/15

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Co-PI: A Multi-Modal Assessment of Chronic Cerebrospinal Venous Insufficiency, National MS Society (RC 1004-A-5), 5% effort, 7/1/10 - 6/30/12

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Mei Lu, MD, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National MS Society grant RC1004-A-5, 2010-2012,

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Heather L. Gornik, MD, MPH, RPVI and
    7. Scientific Advisory Boards:

    1. Non Profit, Roy Greenberg IDE Internal DSMB

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Vascular Medicine; (2) Current Treatment Options in Cardiovascular Medicine

    Patents:

    1. 1. Non-invasive diagnosis of lower extremity peripheral artery disease by oscillometric means. 2. Remote monitoring of anticoagulation

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Cleveland Clinic

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical procedures or imaging studies:

    1. Medical Director, Non Invasive Vascular Laboratory, Cleveland Clinic

    Research Support, Commercial Entities:

    1. Research funding for studies related to peripheral artery disease. Theravasc, Astra-Zeneca.

    Research Support, Government Entities:

    1. Research funding for ATTRACT DVT Trial --- NHLBI via Wash U St. Louis

    Research Support, Academic Entities:

    1. Research funding for ATTRACT DVT Trial --- NHLBI via Wash U St. Louis

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License fee payments, Technology or Inventions:

    1. For patent related to non-invasive diagnosis of lower extremity peripheral artery disease by non invasive means

    Royalty Payments, Technology or Inventions:

    1. For patent related to remote monitoring of anticoagulation

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Esther Soo H. Kim, MD, MPH, RPVI
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Philips ultrasound - educational consultant

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. (1) GE - grant support: provides contrast for one of my ultrasound studies

    Clinical Procedures or Imaging Studies:

    1. Cleveland Clinic Non-Invasive Vascular Laboratory, vascular ultrasound, 15% effort, reader in the lab since 2008

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Multiple Sclerosis Society

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (CID), Mellen Center for Multiple Sclerosis Treatment and Research (RJF, AR-G), Heart and Vascular Institute, Cardiovascular Medicine, Non-Invasive Vascular Laboratory (AG, HLG, ESHK), and Neurological Institute, Cerebrovascular Center (ML), Cleveland Clinic, Cleveland, OH.
  1. Correspondence to:
    kims{at}ccf.org
View Full Text

Article usage

Article usage: October 2013 to April 2023

AbstractFullPdfSource
Oct 2013661927Highwire
Nov 201347937Highwire
Dec 2013231510Highwire
Jan 201410229Highwire
Jan 20140114pmc
Feb 20148002Highwire
Mar 20145164Highwire
Apr 20148891Highwire
May 20148413Highwire
Jun 201459104Highwire
Jul 20142001Highwire
Aug 20142442Highwire
Sep 20143321Highwire
Oct 20142622Highwire
Nov 20142103Highwire
Dec 2014803Highwire
Jan 2015801Highwire
Jan 2015091pmc
Feb 2015401Highwire
Feb 20150100pmc
Mar 20153721Highwire
Mar 2015090pmc
Apr 20152735Highwire
Apr 2015070pmc
May 20151711Highwire
May 20150122pmc
Jun 20152611Highwire
Jun 2015054pmc
Jul 20152815Highwire
Jul 2015061pmc
Aug 20151811Highwire
Aug 2015080pmc
Sep 20152401Highwire
Sep 2015062pmc
Oct 20151302Highwire
Oct 2015060pmc
Nov 20151317Highwire
Nov 2015091pmc
Dec 20152221Highwire
Dec 2015060pmc
Jan 20163106Highwire
Jan 201601415pmc
Feb 20163327Highwire
Feb 2016051pmc
Mar 20161104Highwire
Mar 2016051pmc
Apr 20162621Highwire
Apr 2016040pmc
May 20162021Highwire
May 2016021pmc
Jun 20163255Highwire
Jun 2016093pmc
Jul 20161724Highwire
Jul 2016043pmc
Aug 20162326Highwire
Aug 2016062pmc
Sep 201643619Highwire
Sep 2016091pmc
Oct 201626219Highwire
Oct 2016021pmc
Nov 201623512Highwire
Nov 2016090pmc
Dec 20163311Highwire
Dec 2016050pmc
Jan 20172942Highwire
Jan 2017060pmc
Feb 20172817Highwire
Feb 2017041pmc
Mar 20172640Highwire
Mar 2017042pmc
Apr 20172757Highwire
Apr 2017011pmc
May 201712215Highwire
May 2017034pmc
Jun 20172400Highwire
Jun 2017145pmc
Jul 20171951Highwire
Jul 2017033pmc
Aug 20172830Highwire
Aug 20171910pmc
Sep 20171722Highwire
Sep 2017078pmc
Oct 20172010Highwire
Oct 2017055pmc
Nov 20171811Highwire
Nov 2017044pmc
Dec 20170103Highwire
Jan 20180113Highwire
Feb 20184150Highwire
Mar 20188301Highwire
Apr 20184218Highwire
Apr 2018199pmc
May 20186226Highwire
Jun 20181379Highwire
Jun 2018022pmc
Jul 20180363Highwire
Aug 20180221Highwire
Aug 2018068pmc
Sep 20180246Highwire
Oct 20181163Highwire
Nov 20183251Highwire
Dec 20185192Highwire
Jan 20195211Highwire
Feb 201915215Highwire
Mar 201913198Highwire
Apr 201913127Highwire
May 201915225Highwire
Jun 201961810Highwire
Jul 201914211Highwire
Aug 201916729Highwire
Sep 2019396Highwire
Oct 2019796Highwire
Nov 20192249Highwire
Dec 201942712Highwire
Jan 20206125Highwire
Feb 2020275Highwire
Mar 2020254Highwire
Apr 2020041Highwire
May 2020082Highwire
Jun 2020155Highwire
Jul 20201129Highwire
Aug 20200103Highwire
Sep 20205245Highwire
Oct 20203268Highwire
Nov 20202179Highwire
Dec 20206134Highwire
Jan 2021163Highwire
Feb 20213103Highwire
Mar 20213179Highwire
Apr 20212910Highwire
May 2021387Highwire
Jun 20214105Highwire
Jul 202132014Highwire
Aug 202192610Highwire
Sep 20212155Highwire
Oct 202182320Highwire
Nov 20211711Highwire
Dec 20214126Highwire
Jan 20225131Highwire
Feb 20223222Highwire
Mar 20225144Highwire
Apr 20220143Highwire
May 2022487Highwire
Jun 2022044Highwire
Jul 2022191Highwire
Aug 20221194Highwire
Sep 202233613Highwire
Oct 20223214Highwire
Nov 202275110Highwire
Dec 20226189Highwire
Jan 20238267Highwire
Feb 20233192Highwire
Mar 2023262Highwire
Apr 2023225Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles